Diabetes / GLP-1
Rybelsus cost with insurance.
Rybelsus (oral semaglutide) costs $25–$300/month for most commercially insured patients in 2026, classified as Tier 2 or 3 on most plans, with a NovoCare savings card available for eligible commercial-plan patients.
Sample data — not yet verifiedNo prior authTier 2
$998
List price (1 month)
$822
Cash discount
$768
Mail order
Related medications
See how Rybelsus compares
FAQ
Rybelsus cost questions
Why is Rybelsus so expensive?
Rybelsus is a brand-name diabetes / glp-1 medication, list price ~$998/month, because it's still under patent — generics aren't yet available. Insurance can bring this down significantly once your deductible is met.
Does insurance cover it?
Most major insurance plans cover Rybelsus as a Tier 2 drug. Coverage varies by plan — use the calculator above for a plan-specific estimate.
Is there a generic for Rybelsus?
No generic for semaglutide is currently FDA-approved. The closest cost-saving options are manufacturer self-pay programs, which can drop the price to around $768/month for eligible patients.
What if my insurance denies it?
If your prior authorization is denied, options include: appealing with your prescriber, switching to a similar covered drug in the same therapeutic class, or using the manufacturer's self-pay program. The calculator above shows all four payment paths.
Data sources
Source URLs for Rybelsus have not yet been verified. Estimates below are modeled from general public pricing patterns.
- • Manufacturer published pricing pages
- • NADAC National Average Drug Acquisition Cost
- • Carrier-published formulary tiers (where known)
- • Cost Plus Drugs / mail-order public pricing
- • FDA Orange Book (generic availability)